Biotech | November 17, 2021
Pfizer seeks EUA from U.S. FDA for Covid-19 drug
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Launching in 2022, its availability will be expanded to the global market
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
The 50-bed hospital is positioned to address complexities specific to women and children, going beyond a birthing facility
This test is inexpensive and results are available immediately as compared to the genetic test
The octocopter has successfully delivered 50 vials of Covid-19 vaccines along with syringes in a special container from Chandapura PHC to Haragadde PHC
The company performed particularly well in operational eco-efficiency, environmental and social reporting
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
